KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Change in Cash (2016 - 2025)

Exact Sciences (EXAS) has disclosed Change in Cash for 16 consecutive years, with $167.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Cash rose 1294.93% to $167.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $349.4 million, a 11595.89% increase, with the full-year FY2025 number at $349.4 million, up 11595.89% from a year prior.
  • Change in Cash was $167.0 million for Q4 2025 at Exact Sciences, up from $131.9 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $310.0 million in Q2 2025 to a low of -$740.1 million in Q2 2021.
  • A 5-year average of -$26.8 million and a median of $18.3 million in 2022 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: crashed 25851.15% in 2021, then surged 1294.93% in 2025.
  • Exact Sciences' Change in Cash stood at $41.7 million in 2021, then plummeted by 82.76% to $7.2 million in 2022, then surged by 105.45% to $14.8 million in 2023, then fell by 18.94% to $12.0 million in 2024, then soared by 1294.93% to $167.0 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Change in Cash are $167.0 million (Q4 2025), $131.9 million (Q3 2025), and $310.0 million (Q2 2025).